Main Article Content
COVID-19, Schizophrenia, Patient Satisfaction, Fear, Anxiety Disorders, Anxiety, Depression, Inpatients, Risk Factors, Epidemiologic Factors, Multivariate Analysis, Cross-Sectional Studies, Lebanon
Background: The patient's evaluation of treatment and its associated outcomes define the treatment satisfaction. The quality of treatment satisfaction and healthcare service has been affected by depression, anxiety and fear of the current coronavirus disease 2019 (COVID-19) pandemic.
Objective: Therefore, this study aimed to assess factors associated with treatment satisfaction among Lebanese inpatients with schizophrenia, namely depression, anxiety and fear of COVID-19.
Methods: A cross-sectional study was conducted between September and November 2020, enrolled 118 patients with chronic schizophrenia consecutively admitted to Psychiatric Hospital of the Cross, Lebanon. The Functional Assessment of Chronic Illness Therapy-Treatment Satisfaction-Patient Satisfaction Scale (FACIT-TS-PS) was used to assess treatment satisfaction, the Lebanese Anxiety Scale -10 (LAS-10) was used to assess anxiety, Montgomery-Asberg Depression Rating Scale (MADRS) to assess depression and the Fear of COVID-19 Scale to assess the level of fear of the COVID-19 pandemic.
Results: The mean scores of the scales were as follows: treatment satisfaction (65.20; SD 16.11; median=71), LAS-10 (13.65; SD 6.02), MADRS (9.09; SD 6.69) and fear of COVID-19 (18.59; SD 6.78). Higher depression (r= -0.46, p<0.001) was significantly associated with lower treatment satisfaction. Female gender (beta=7.51, p=0.029) was significantly associated with higher treatment satisfaction score. Fear of COVID-19 did not show any significant association with the treatment satisfaction score.
Conclusions: Results of this study found that depression and gender were associated with treatment satisfaction among inpatients with schizophrenia. No association has been found between fear of COVID-19 and treatment satisfaction among those patients. More research is warranted to evaluate treatment satisfaction and associated factors among chronic inpatients with schizophrenia, specifically during the COVID-19 pandemic, in order to improve treatment satisfaction and subjective well-being of patients.
2. Shikiar R, Rentz AM. Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value Health. 2004;7(2):204-215. https://doi.org/10.1111/j.1524-4733.2004.72252.x
3. Peuskens J. Clinical effectiveness in adults with chronic schizophrenia. Eur Neuropsychopharmacol. 2004;14 Suppl 4:S453-S459. https://doi.org/10.1016/j.euroneuro.2004.08.004
4. Chue P. The relationship between patient satisfaction and treatment outcomes in schizophrenia. J Psychopharmacol. 2006;20(6 Suppl):38-56. https://doi.org/10.1177/1359786806071246
5. Carrick R, Mitchell A, Powell RA, Lloyd K. The quest for well-being: a qualitative study of the experience of taking antipsychotic medication. Psychol Psychother. 2004;77(Pt 1):19-33. https://doi.org/10.1348/147608304322874236
6. Afe T, Bello-Mojeed M. Schizophrenia treatment satisfaction in Nigeria. Psychiatr Serv. 2014;65(5):697-698. https://doi.org/10.1176/appi.ps.650502
7. Ladea M, Barbu CM, Juckel G. Treatment effectiveness in patients with schizophrenia as measured by the ASSESS battery - first longitudinal data. Psychiatr Danub. 2015;27(4):364-370.
8. Fujikawa M, Togo T, Yoshimi A, et al. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(3):755-760. https://doi.org/10.1016/j.pnpbp.2007.12.002
9. Stabell LA, Gjestad R, Kroken RA, Løberg EM, Jørgensen HA, Johnsen E. Predictors of treatment satisfaction in antipsychotic-naïve and previously medicated patients with acute-phase psychosis. Nord J Psychiatry. 2019;73(6):349-356. https://doi.org/10.1080/08039488.2019.1636134
10. Dua D, Hertz D, Howe T. Overall treatment satisfaction with schizophrenia therapies: analysis from patient, physician and caregiver perspectives. Value Health. 2018;21:S186–-S187. https://doi.org/10.1016/j.jval.2018.04.1294
11. McCabe R, Healey PGT. Miscommunication in Doctor-Patient Communication. Top Cogn Sci. 2018;10(2):409-424. https://doi.org/10.1111/tops.12337
12. Pestana-Santos A, Loureiro L, Santos V, Carvalho I. Patients with schizophrenia assessing psychiatrists' communication skills. Psychiatry Res. 2018;269:13-20. https://doi.org/10.1016/j.psychres.2018.08.040
13. Schneider B, Scissons H, Arney L, et al. Communication between people with schizophrenia and their medical professionals: a participatory research project. Qual Health Res. 2004;14(4):562-577. https://doi.org/10.1177/1049732303262423
14. Hornung WP, Klingberg S, Feldmann R, Schonauer K, Schulze Mönking H. Collaboration with drug treatment by schizophrenic patients with and without psychoeducational training: results of a 1-year follow-up. Acta Psychiatr Scand. 1998;97(3):213-219. https://doi.org/10.1111/j.1600-0447.1998.tb09990.x
15. Lotfi M, Zamanzadeh V, Valizadeh L, Khajehgoodari M. Assessment of nurse-patient communication and patient satisfaction from nursing care. Nurs Open. 2019;6(3):1189-1196. https://doi.org/10.1002/nop2.316
16. Alimena S, Air ME. Trust, Satisfaction, and Confidence in Health Care Providers Among Student and Professional Dancers in France. Med Probl Perform Art. 2016;31(3):166-173. https://doi.org/10.21091/mppa.2016.3030
17. Kim JH, Ann JH, Kim MJ. Relationship between improvements of subjective well-being and depressive symptoms during acute treatment of schizophrenia with atypical antipsychotics. J Clin Pharm Ther. 2011;36(2):172-178. https://doi.org/10.1111/j.1365-2710.2010.01175.x
18. McCabe R, Saidi M, Priebe S. Patient-reported outcomes in schizophrenia. Br J Psychiatry. 2007;50(suppl):s21-s28. https://doi.org/10.1192/bjp.191.50.s21
19. Freudenreich O, Cather C, Evins AE, Henderson DC, Goff DC. Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight. J Clin Psychiatry. 2004;65(10):1372-1376. https://doi.org/10.4088/jcp.v65n1012
20. WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int (accessed Jan 24, 2021).
21. Shader RI. COVID-19 and Depression. Clin Ther. 2020;42(6):962-963. https://doi.org/10.1016/j.clinthera.2020.04.010
22. Kozloff N, Mulsant BH, Stergiopoulos V, Voineskos AN. The COVID-19 Global Pandemic: Implications for People With Schizophrenia and Related Disorders. Schizophr Bull. 2020;46(4):752-757. https://doi.org/10.1093/schbul/sbaa051
23. Deriba BS, Geleta TA, Beyane RS, Mohammed A, Tesema M, Jemal K. Patient Satisfaction and Associated Factors During COVID-19 Pandemic in North Shoa Health Care Facilities. Patient Prefer Adherence. 2020;14:1923-1934. https://doi.org/10.2147/ppa.s276254
24. Peipert JD, Beaumont JL, Bode R, Cella D, Garcia SF, Hahn EA. Development and validation of the functional assessment of chronic illness therapy treatment satisfaction (FACIT TS) measures. Qual Life Res. 2014;23(3):815-824. https://doi.org/10.1007/s11136-013-0520-8
25. FACIT Group. FACIT-TS-PS Languages. https://www.facit.org/measure-languages/FACIT-TS-PS-Languages (accessed Feb 8, 2021).
26. Hallit S, Obeid S, Haddad C, et al. Construction of the Lebanese Anxiety Scale (LAS-10): a new scale to assess anxiety in adult patients. Int J Psychiatry Clin Pract. 2020;24(3):270-277. https://doi.org/10.1080/13651501.2020.1744662
27. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389. https://doi.org/10.1192/bjp.134.4.382
28. Hallit S, Obeid S, El Hage W, Kazour F. Validation of the Arabic version of the MADRS scale among Lebanese patients with depression. Encephale. 2019;45(3):195-199. https://doi.org/10.1016/j.encep.2018.05.004
29. Alyami M, Henning M, Krägeloh CU, Alyami H. Psychometric Evaluation of the Arabic Version of the Fear of COVID-19 Scale. Int J Ment Health Addict. 2020; [ahead of print] https://doi.org/10.1007/s11469-020-00316-x
30. Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code Biol Med. 2008;3:17. https://doi.org/10.1186/1751-0473-3-17
31. Fakhoury WK, Wright D, Wallace M. Prevalence and extent of distress of adverse effects of antipsychotics among callers to a United Kingdom National Mental Health Helpline. Int Clin Psychopharmacol. 2001;16(3):153-162. https://doi.org/10.1097/00004850-200105000-00004
32. Karow A, Pajonk FG. Insight and quality of life in schizophrenia: recent findings and treatment implications. Curr Opin Psychiatry. 2006;19(6):637-641. https://doi.org/10.1097/01.yco.0000245754.21621.c9
33. Worldometer. Lebanon Coronavirus: 282,249 cases and 2,374 deaths. https://www.worldometers.info/coronavirus/country/lebanon/ (accessed Jan 25, 2021).
34. Middelboe T, Schjødt T, Byrsting K, Gjerris A. Ward atmosphere in acute psychiatric in-patient care: patients' perceptions, ideals and satisfaction. Acta Psychiatr Scand. 2001;103(3):212-219. https://doi.org/10.1034/j.1600-0447.2001.00102.x
35. Bener A, Ghuloum S. Gender difference on patients' satisfaction and expectation towards mental health care. Niger J Clin Pract. 2013;16(3):285-291. https://doi.org/10.4103/1119-3077.113448
36. Kuosmanen L, Hätönen H, Jyrkinen AR, Katajisto J, Välimäki M. Patient satisfaction with psychiatric inpatient care. J Adv Nurs. 2006;55(6):655-663. https://doi.org/10.1111/j.1365-2648.2006.03957.x